Role and clinical application of next-generation sequencing (NGS) for ovarian cancer

被引:4
作者
Lim, Myong Cheol [1 ,2 ,3 ]
Randall, Leslie M. [3 ]
机构
[1] Natl Canc Ctr, Canc Healthcare Res Branch, Ctr Uterine Canc, Goyang, South Korea
[2] Natl Canc Ctr, Ctr Clin Trials, Res Inst & Hosp, Dept Canc Control & Populat Hlth,Grad Sch Canc Sc, Goyang, South Korea
[3] Univ Calif, Irvine Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Orange, CA USA
关键词
HOMOLOGOUS RECOMBINATION GENES; SOMATIC MUTATIONS; FALLOPIAN-TUBE; PERITONEAL; GERMLINE; BRCA2; SURVIVAL;
D O I
10.3802/jgo.2017.28.e51
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:4
相关论文
共 20 条
[1]   Integrated genomic analyses of ovarian carcinoma [J].
Bell, D. ;
Berchuck, A. ;
Birrer, M. ;
Chien, J. ;
Cramer, D. W. ;
Dao, F. ;
Dhir, R. ;
DiSaia, P. ;
Gabra, H. ;
Glenn, P. ;
Godwin, A. K. ;
Gross, J. ;
Hartmann, L. ;
Huang, M. ;
Huntsman, D. G. ;
Iacocca, M. ;
Imielinski, M. ;
Kalloger, S. ;
Karlan, B. Y. ;
Levine, D. A. ;
Mills, G. B. ;
Morrison, C. ;
Mutch, D. ;
Olvera, N. ;
Orsulic, S. ;
Park, K. ;
Petrelli, N. ;
Rabeno, B. ;
Rader, J. S. ;
Sikic, B. I. ;
Smith-McCune, K. ;
Sood, A. K. ;
Bowtell, D. ;
Penny, R. ;
Testa, J. R. ;
Chang, K. ;
Dinh, H. H. ;
Drummond, J. A. ;
Fowler, G. ;
Gunaratne, P. ;
Hawes, A. C. ;
Kovar, C. L. ;
Lewis, L. R. ;
Morgan, M. B. ;
Newsham, I. F. ;
Santibanez, J. ;
Reid, J. G. ;
Trevino, L. R. ;
Wu, Y. -Q. ;
Wang, M. .
NATURE, 2011, 474 (7353) :609-615
[2]   Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO) [J].
Choi, Min Chul ;
Lim, Myong Cheol ;
Suh, Dong Hoon ;
Song, Yong Jung ;
Kim, Tae-Joong ;
Chang, Suk-Joon ;
Kim, Jae-Weon .
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2016, 27 (04)
[3]   Germline Mutations of BRCA1 and BRCA2 in Korean Ovarian Cancer Patients Finding Founder Mutations [J].
Choi, Min Chul ;
Heo, Jin-Hyung ;
Jang, Ja-Hyun ;
Jung, Sang Geun ;
Park, Hyun ;
Joo, Won Duk ;
Lee, Chan ;
Lee, Je Ho ;
Lee, Jun Mo ;
Hwang, Yoon Young ;
Kim, Seung Jo .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (08) :1386-1391
[4]   Comparison of Clinical Outcomes of BRCA1/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients [J].
Eoh, Kyung Jin ;
Park, Hyung Seok ;
Park, Ji Soo ;
Lee, Seung-Tae ;
Han, Jeongwoo ;
Lee, Jung-Yun ;
Kim, Sang Wun ;
Kim, Sunghoon ;
Kim, Young Tae ;
Nam, Eun Ji .
CANCER RESEARCH AND TREATMENT, 2017, 49 (02) :408-415
[5]  
Gradishar W, 2017, ONCOLOGIST IN PRESS
[6]   Homologous recombination deficiency (HRD) score and niraparib efficacy in high grade ovarian cancer [J].
Haluska, P. ;
Timms, K. M. ;
AlHilli, M. ;
Wang, Y. ;
Hartman, A. M. ;
Jones, J. ;
Gutin, A. ;
Sangale, Z. ;
Neff, C. ;
Lynchbury, J. ;
Rudolph-Owen, L. ;
Becker, M. A. ;
Agarwal, S. ;
Wilcoxen, K. M. .
EUROPEAN JOURNAL OF CANCER, 2014, 50 :72-73
[7]   Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer [J].
Hennessy, Bryan T. J. ;
Timms, Kirsten M. ;
Carey, Mark S. ;
Gutin, Alexander ;
Meyer, Larissa A. ;
Flake, Darl D., II ;
Abkevich, Victor ;
Potter, Jennifer ;
Pruss, Dmitry ;
Glenn, Pat ;
Li, Yang ;
Li, Jie ;
Gonzalez-Angulo, Ana Maria ;
McCune, Karen Smith ;
Markman, Maurie ;
Broaddus, Russell R. ;
Lanchbury, Jerry S. ;
Lu, Karen H. ;
Mills, Gordon B. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (22) :3570-3576
[8]   Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation [J].
Kaufman, Bella ;
Shapira-Frommer, Ronnie ;
Schmutzler, Rita K. ;
Audeh, M. William ;
Friedlander, Michael ;
Balmana, Judith ;
Mitchell, Gillian ;
Fried, Georgeta ;
Stemmer, Salomon M. ;
Hubert, Ayala ;
Rosengarten, Ora ;
Steiner, Mariana ;
Loman, Niklas ;
Bowen, Karin ;
Fielding, Anitra ;
Domchek, Susan M. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03) :244-250
[9]   Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial [J].
Ledermann, Jonathan A. ;
Harter, Philipp ;
Gourley, Charlie ;
Friedlander, Michael ;
Vergote, Ignace ;
Rustin, Gordon ;
Scott, Clare ;
Meier, Werner ;
Shapira-Frommer, Ronnie ;
Safra, Tamar ;
Matei, Daniela ;
Fielding, Anitra ;
Spencer, Stuart ;
Rowe, Philip ;
Lowe, Elizabeth ;
Hodgson, Darren ;
Sovak, Mika A. ;
Matulonis, Ursula .
LANCET ONCOLOGY, 2016, 17 (11) :1579-1589
[10]   BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients [J].
Lim, Myong Cheol ;
Kang, Sokbom ;
Seo, Sang-Soo ;
Kong, Sun-Young ;
Lee, Bo-Yon ;
Lee, Seon-Kyung ;
Park, Sang-Yoon .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (11) :1593-1599